Key points
Introduction
Platelets have been associated with tumor progression and metastatic dissemination through platelettumor cell (TC) interactions [1] [2] [3] [4] [5] [6] [7] . Platelet-TC interactions may contribute to tumor progression in several ways, including enhancing cancer-related coagulation, and providing a TC "shroud" to shield them from the immune system 8 . The presence of cancer increases platelet production, which has been associated with poorer outcomes in multiple cancers 9, 10 . Platelets can stimulate proliferation of human and murine cancer cells in a manner that does not require platelet-tumor contact 11 . However, the platelet-cancer axis still remains unsolved and is an area of active investigation.
Platelets and other cells release microparticles (MPs) into the plasma in response to receptor agonists and shear stress 12 . At least 45% of plasma-borne MPs are platelet-derived microparticles (PMPs) 13, 14 . PMP release increases in individuals bearing solid tumors, but roles of PMPs in cancer progression are incompletely understood 15, 16 . PMPs are enriched in platelet miRNAs, a small cohort of which are present at high copy number, accounting for the bulk of plasma miRNAs [17] [18] [19] [20] [21] . Purified PMPs are able to transfer at least some miRNA content to cells following co-incubation in vitro, and regulate gene expression [22] [23] [24] . Several miRNAs enriched in PMPs, including miR-27a, miR-24, miR-155, miR-195, let-7a/b and miR-223, target both tumor suppressor genes and oncogenes, in multiple cancer types, and have been identified as diagnostic and prognostic markers of malignancy, and implicated in therapy resistance . Tumor neovasculature is highly permeable, which we predicted might allow circulating microparticles direct access to tumor cells. In this study, we investigated PMP infiltration in solid tumors, transfer of platelet-derived miRNAs to tumor cells, and cellular and physiological effects.
For personal use only. on May 19, 2017 . by guest www.bloodjournal.org From
Methods

Tumor allografts and immune-induced thrombocytopenia
x 10
6 cells/200 μL of Hank's Balanced Salt Solution suspension was injected subcutaneously into the shaved flank of 8-week-old mice. Thrombocytopenia was induced by intraperitoneal injection of 50 mg/kg ratanti-mouse CD41 antibodies. Platelet count was assessed by HEMAVET analysis, and was <20% of starting counts after 24 h. In some cases mice were injected i.p. with 100 mg/kg 4TU in 20% dimethyl sulfoxide (DMSO)/80% corn oil, or vehicle. Tumor volume was calculated as described 47 . Tumors were resected from euthanized mice, cleaned of fat, skin and connective tissue for further processing.
miRNA:mRNA target adduct formation and screening
Cells suspended in 500 μL fractionation buffer (20 mM Tris-Cl pH 7.4,100 mM NaCl, 2 mM MgOAc, 5
mM KCl, protease inhibitor cocktail [Roche, Indianapolis, IN, USA]) were dounce homogenized followed by sonication. Lysates were treated with 1 U/μl RNase T1 (Fisher, Pittsburgh, PA, USA) for 15 min at 22°C, followed by RNase inhibition with 10 mM MnCl 2 . T4 PNK minus 1 U/μl + 100 mM ATP, 5 mM DTT was added, 40 min at 10°C. RNA ligation was carried out with 0.2 U/μl T4 RNA ligase, 16 h at 4°C. RNA was extracted in TRIzol and resuspended in DEPC-treated H 2 O, followed 1 μl PNK and no ATP for 40 min at 10°C, and poly(dA) tailing and 1 st strand cDNA synthesis with the NCode kit (see Supplemental Methods) 48 . cDNA libraries were subjected to Taq PCR using miR-specific 5' oligonucleotides and universal poly(dT) 3' primers.
Products were subcloned by direct ligation of the reaction mixture into the pCR2.1 TA vector (Invitrogen), and ligation reactions were transformed into DH5α E. coli for ampicillin selection, colony propagation, plasmid DNA minipreps (Qiagen, Valencia, CA, USA) and sequencing.
Results
Platelet microparticles infiltrate solid tumors.
Circulating platelet-derived microparticles (PMPs) harbor microRNAs (miRNAs) and can transfer platelet-derived miRNAs to endothelium and leukocytes 22, 23, 49 . Because tumor blood vessels are highly permeable due to endothelial dysfunction and poor pericyte coverage 50 , and PMP release correlates with solid tumor growth and metastasis 4, 16, 51 , we considered whether tumor cells (TCs) in solid tumors are targets of PMPs.
We observed PMP infiltration, indicated by antibodies to α IIb integrin (CD41) -a platelet/megakaryocytespecific receptor and a PMP marker 52 -in the extravascular tumor environment as indicated by von Willebrand
Factor staining for blood vessels, in grade II/III solid tumors derived from human patients, but not in adjacent normal tissue, in multiple cancer types ( Figure 1A ). The puncta ranged in diameter from ~ 100 -1000 nm, the diameter range of PMPs 53, 54 , and were Annexin V-positive ( Figure 1B ), indicating phosphatidylserine exposure on the outer leaflet, a characteristic of MPs and apoptotic cells. Most but not all Annexin V-positive puncta in the tumor sections also contained α IIb integrin, consistent with PMPs being the major MP fraction in the infiltrates ( Figure 1B ). Examination of tissue sections spiked with freshly isolated platelets and stained with α IIb integrin antibodies confirmed that the platelet-derived intratumoral material consisted of platelet fragments, smaller than intact platelets ( Figure 1C ). PMP tumor infiltration was observed across tumor grades in lung and colon cancer subtypes, but extravascular PMPs were not observed in paired, uninvolved normal tissues except for a few cases ( Figure 1D -G, Table 1 ). In these latter cases, PMP infiltration was only evident in normal tissue adjacent to the tumor, suggesting that infiltration reflected a specific effect of proximity to the tumor microenvironment ( Figure 1F ).
To gain mechanistic insight, we employed an ectopic solid tumor allograft model in mice using Lewis lung carcinoma (LLC) cells injected as a bolus s.c. into mouse flanks 55 . PMPs were observed infiltrating LLC allografted tumors in mice (Figure 2A ), similar to human tumors ( Figure 1 ). CD63, a marker for both PMPs and exosomes 13 , overlapped with α IIb integrin in PMP-like structures -CD63-only exosomes were also evident - Figure 2C ). PMPs were also associated with GFP-positive TCs isolated from resected tumors from NIH3T3 cells transformed with GFP-HRAS(G12V) 47,60 (supplemental Figure 1A) . Fewer PMPs appeared associated with TCs derived from 7 d tumors (supplemental Figure 1B) , suggesting that robust neovascularization precludes PMP extravasation in solid tumors. TCs extracted at day 21, 24 h after immune-induced thrombocytopenia, showed substantially reduced PMPs (3.1% ± 2.2 of TCs), indicating that the MPs were derived from blood platelets (supplemental Figure 1C) . Many of the PMPs were attached to TC surfaces, and α IIb integrin could also be seen internalized in HRAS-containing recycling endosomes, suggesting PMP cargo internalization (supplemental Figure 1D ) 61, 62 . In some cells, α IIb integrin was broadly distributed at the plasma membrane, indicating redistribution of PMPderived proteins in the TCs, either as a result of plasma membrane fusion, transport of internalized protein to the target cell membrane, or expression of platelet-derived mRNA (supplemental Figure 1E) . Thus, platelet microparticles can undergo extravasation beyond the blood circulation in solid tumors and associate with tumor cells.
PMPs transfer platelet RNA, including miRNAs, to tumor cells in solid tumors in vivo and in vitro.
We considered whether infiltrating PMPs could deliver RNA cargo to TCs. We transfused platelets, In addition to DNA/RNA, AO can also label platelet granules 63 . To confirm that transferred plateletderived material included RNA, and to investigate platelet miRNAs, we transfected human platelets with
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To study PMP RNA transfer further, we utilized human platelets, from which we could more easily derive substantial quantities of PMPs. We stimulated ex vivo human platelets to release PMPs (supplemental Figure 3A) , and incubated collected PMPs with LLCs in culture 23 . After 1 h PMP exposure, most LLC cells were decorated with α IIb integrin puncta which resembled the intratumoral PMPs, and these puncta were removed by trypsin, suggesting a protein-mediated anchorage to the target cell surface (supplemental Figure   3B ). Similar to TCs ex vivo, LLC cells exposed to PMPs from control-transfected platelets showed no FAM fluorescence ( Figure 2I ), whereas LLC cells exposed to PMPs from platelets transfected with FAM-siRNA showed cytosolic FAM + fluorescence distinct from the α IIb integrin structures, selectively in PMP-targeted cells ( Figure 2J ). Thus, PMPs can deliver miRNA to TCs in vitro, consistent with previous reports in other systems 23, 24 . Together, these data demonstrate that platelet-derived siRNA (miRNA mimic) transfers horizontally to tumor cells in solid tumors via infiltrating PMPs, and transferred siRNA is not sequestered in PMPs but is distributed in the target cell cytosol.
Platelet-derived miRNAs transferred to tumor cells in solid tumors.
We sought to characterize platelet-derived miRNAs transferred to TCs via microparticles. Following in vitro PMP exposure, we extracted RNA from PMP-stripped TCs. PCR for previously identified abundant miRNAs in PMPs, many of which are involved in tumor progression 17, 19, 21, [65] [66] [67] , indicated enrichment of several miRNAs in LLCs following PMP exposure ( Figure 3A ). We generated LLC cells stably expressing E2-Crimson fluorophore to allow ex vivo TC isolation from resected tumors by single cell sorting. Several miRNAs were upregulated in TCs in vivo compared to cells in culture as indicated by conventional PCR ( Figure 3B ) and quantitative RT-PCR (qPCR, Figure 3C ), including miR-27a, miR-24, miR-25, miR-191, miR-9, and let-7a.
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However, miR-24 and miR-27a were evident only in PMP-treated LLC cells but not untreated cells in vitro and in ex vivo TCs by conventional PCR (Figure 3A-B) . These miRNAs were each elevated > 9-fold ex vivo compared to cells in culture ( Figure 3C ), indicating that these miRNAs had been either expressed selectively in tumors, or transferred to TCs in vivo.
To determine whether the additional miRNAs in TCs ex vivo were platelet-derived, we crossed CA-loxP (>)-GFPstop-loxP(>)-Uprt C57Bl/6 mice with Pf4-Cre C57Bl/6 mice, to generate CA>Uprt/Pf4-Cre double heterozygotes for Cre-induced expression of T. gondii uracil phosphoribosyltransferase (UPRT) selectively in megakaryocytes/platelets ( Figure 3D ). This enzyme is required for incorporation of 4-thiouracil (4TU), a cellpermeable, non-native uracil variant, into nascent mammalian RNA; thus, only megakaryocytes can produce thio-RNA in these mice upon 4TU exposure, yielding platelets selectively harboring thio-RNA which can be isolated by thiol-biotinylation and avidin chromatography ( Figure 3D ) 68 . We seeded LLC-E2-Crimson cell tumors in the flanks of CA>Uprt/Pf4-Cre heterozygotes or Pf4-Cre controls, followed by 4TU i.p. injection, TC collection and biotin/avidin isolation of platelet-derived RNA in PMP-stripped TCs ( Figure 3D ). Both miR-24
and miR-223 were observed as thio-RNA extracted from isolated TC RNA from Pf4-Cre/CA>Uprt mice, but not from TCs from Pf4-Cre mice, demonstrating in vivo transfer of these platelet-derived miRNAs to TCs ( Figure 3E ). QPCR from thio-RNA samples revealed significant increases over control in each of the screened miRNAs, with the greatest increase observed in miR-24 ( Figure 3F ). 4TU-RNA in TCs was platelet-derived and not from PMP-mediated transfer of UPRT enzyme from platelets to tumor cells, as HA-UPRT was expressed selectively in platelets in Pf4-Cre/CA>Uprt mice, but we did not detect HA-UPRT in PMPs nor in ex vivo TCs in these mice, or in control mice (supplemental Figure 4) ; thus, UPRT-driven RNA labeling was restricted to megakaryocytes/platelets in this system. Together, these data demonstrate that platelet-derived miRNAs transfer to TCs in solid tumors in vivo, and miR-24 was a major species in the transfer. Attachment of platelet-derived
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PMPs induce tumor cell apoptosis in a miR-24-dependent manner.
We caspase-3 and apoptosis more broadly has been observed in other systems and various disease states 70, 71 .
PMPs inhibit tumor growth in a miR-24-dependent manner.
We tested tumor growth effects of PMPs in vivo. Daily transfusion of freshly generated human PMPs into mice bearing LLC or MC-38 tumors, beginning at d 8, markedly inhibited tumor growth, which was abrogated by transfection with antagomiR-24 prior to allograft implantation ( Figure 4E -F). These results indicate that miR-24 in the transfused PMPs was partially responsible for tumor growth inhibition, which we would predict as miR-24 is conserved between mouse and human, and therefore these homologues have identical seed target sequences and thus, with identical binding affinities, putatively can target the same RNAs.
Transfused PMPs infiltrated tumors and appeared broadly distributed in the intratumoral environment (supplemental Figure 6A ), but neither endogenous nor exogenous PMPs were detected in non-tumor tissue
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PMP depletion in
Identification of tumor cell RNA targets of PMP-derived miR-24
To identify TC RNA targets of PMP-derived miR-24, we modified a method recently described 48 , in which single strand chimeras derived from truncated miRNA:target RNA hybrid pairs are generated in cell lysate fractions ( Figure 6A ). We focused on miR-24 targets, as miR-24 was a major species transferred from
PMPs and a major contributor to growth inhibitory effects of PMPs. Human and murine miR-24-1-5p and -2-5p sequences are identical. We performed miRNA:mRNA ligation reactions on lysates from LLC cells with or without PMP exposure, followed by PCR with miR-24 5' and universal 3' primers, and direct cloning and sequencing of the PCR products. Whereas some insert sequences were either too short or contained misalignments, preventing unambiguous identification of the miRNA-ligated target RNAs (supplemental Table   1 ), several of the miR-24 adduct inserts could be unambiguously assigned. A 21-nt insert corresponded exclusively to Snora75, an H/ACA box small nucleolar RNA (snoRNA), and another independent clone contained a 96-nt segment also corresponding exclusively to Snora75. Hence, some miR-24 adducts included a non-coding RNA (ncRNA) Interestingly, antagomiR-24 had no effect on expression of these RNAs in untreated LLCs, but led to mt-Nd2 upregulation in MC-38 cells both with and without PMPs ( Figure 6D-E) . These results suggest that mt-Nd2 steady state expression is modulated by endogenous miR-24 in MC-38 cells to a greater extent than in LLC cells, and addition of exogenous PMP-derived miR-24 enhances gene suppression in both cell lines. Mt-Nd2
For Figure 6F-G) . Thus, PMP exposure in these TCs induces down-regulation of mt-Nd2 and Snora75 via miR-24.
PMP-derived miR-24 localizes to mitochondria and inhibits tumor cell mitochondrial function.
MiR-24 was broadly distributed in multiple compartments in PMP-exposed cells, including nucleus, nucleoli, mitochondria, and mitochondria-depleted cytoplasm ( Figure 7A ). MiR-24 was recently observed in nucleoli 77 ; these data indicate that miR-24 is also a mitomiR 78 . This multi-organelle localization is consistent with the ability of miR-24 to target and down-regulate RNAs in each compartment.
Mt-Nd2 is a component of the NADH: ubiquinone oxidoreductase (complex I), responsible for mitochondrial oxidative phosphorylation and ROS production 79 . We measured mitochondrial membrane Figure 6 ). However, ATP production was not increased over baseline levels in this case. Platelet-derived mitochondria were not transferred via PMPs to TCs, as we did not detect Mitotracker Red-labeled platelet mitochondria in TCs after PMP generation and exposure (supplemental Figure 9) , and as noted previously, human mt-Nd2 RNA, which is contained within mitochondria, was also not transferred from platelets to PMPs or TCs (supplemental Figure 8) .
Together, these data demonstrate that miR-24, transferred from PMPs to tumor cells, causes mitochondrial dysfunction and tumor growth inhibition.
For We observed PMP infiltration in multiple solid tumor types, and at each tumor grade, but not in unaffected normal tissues. This difference likely reflects increased permeability of tumor neovasculature, which unlike mature blood vessels, is perforated with pores >>100 nm as a result of dysfunctional endothelial junctions, allowing for leak of blood-borne protein complexes and other macromolecular complexes into the intratumoral space 50 . This pore size is permissive for extravascular leak of PMPs, and it is likely that other cellderived MPs as well as exosomes (30-100 nm diameter) invade the tumor microenvironment through these pores. PMP exposure due to vascular leak is therefore likely restricted to solid tumors, distinct from normal tissues, adding PMPs and other microvesicles to the unique composition of the tumor microenvironment.
Mechanisms of PMP attachment and internalization in tumor cells remain to be elucidated, but could involve interactions with multiple receptors such as GP1b (potentially in complex with vWF) 81 , P-selectin 82 , phosphatidylserine receptors on the tumor cell surface 83 , or a combination of these and other interactions.
Interactions between microparticles and cells have been investigated in many contexts, these interactions yield a broad range of outcomes 84, 85 . Endothelium and blood cells are exposed to PMPs, and effects are just beginning to be explored 19, 86 .
PMPs have been shown to transfer miRNAs to cells when co-incubated in vitro,
and to modulate target cell gene expression 23, 24 . For example, PMP incubation with A549 lung carcinoma cells (G) 1x10 6 LLC cells were transfected as indicated, and after 18 h were seeded as allografts by bolus injection into the flanks of WT mice. Beginning at d 8, 1x10 10 PMPs freshly isolated from human platelets were counted and transfused daily by tail vein injection. Tumor volumes were measured daily with calipers. n = 6. *, p < 0.02.
(H) MC-38 cells were transfected and implanted, followed by PMP transfusion, and tumor growth was monitored as in (G). **, p < 0.003. n = 6. All plots, shown ± s.e.m. was isolated from cells 16 hr after exposure to PMPs or blank media. qRT-PCR was performed using 100-bp PCR fragments of each transcript, and relative expression levels were quantified using GAPDH as a 
